Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (6) Autor Amarante,Diogo (1) Andrade,Marcio A (1) Barth,Afonso Luis (1) Borba,Luis A (1) Brodt,Teresa Cristina Z. (1) Cantarelli,Vlademir Vicente (1) Cavalcante,Bianca C. (1) Freitas,Ana Lúcia Peixoto de (1) Gortz,Lucas W. (1) Hackel,Meredith A. (1) Hoban,Daryl J. (1) Inamine,Everton (1) Karlowsky,James A. (1) Lob,Sibylle H. (1) Noblat,A.C.B. (1) Noblat,L. (1) Penteado-Filho,Sergio R (1) Pereira,Fabiana de Souza (1) Rocha,Jaime L. (1) Sahm,Daniel F. (1) Mais... Palavra-chave Imipenem (6) Antibiotic resistance (2) Pseudomonas aeruginosa (2) Acinetobacter (1) Acinetobacter baumannii (1) AmpC (1) Ampicillin/sulbactam (1) Antimicrobial policy (1) Audit system (1) Cefoxitin screening (1) Drug use evaluation (1) Drug use review (1) Ertapenem (1) Inductible beta-lactamases (1) Meningitis (1) Meropenem (1) Neurosurgery (1) Risk factor (1) SMART (1) Screening tests (1) Mais... Tipo do documento Info:eu-repo/semantics/article (5) Info:eu-repo/semantics/other (1) Ano 2017 (1) 2012 (1) 2010 (1) 2008 (1) 2007 (1) 2002 (1) Mais... País Brazil (6) Idioma Inglês (6)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 6 Primeira ... 1 ... Última Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy BJID Tuon,Felipe F.; Gortz,Lucas W.; Rocha,Jaime L.. INTRODUCTION: The aim of this study was to determine risk factors for acquiring carbapenemresistant Pseudomonas aeruginosa bacteremia (CR-PA) and factors associated with in-hospital mortality. METHODS: Seventy-seven cases of bacteremia caused by P. aeruginosa were evaluated in a hospital with high incidence of CR-PA. Clinical and laboratorial factors, and previous use of antibiotics were also evaluated. In one analysis, CR-PA and carbapenem-susceptible P. aeruginosa (CS-PA) bacteremia were compared. A second analysis compared patients who died with survivors. RESULTS: Among 77 P. aeruginosa bacteremia, 29 were caused by CR-PA. Admission to the intensive care unit, higher number of total leukocytes, and previous use of carbapenem were statistically... Tipo: Info:eu-repo/semantics/article Palavras-chave: Pseudomonas aeruginosa; Imipenem; Meropenem; Antibiotic resistance; Risk factor. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000400007 Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem BJID Freitas,Ana Lúcia Peixoto de; Barth,Afonso Luis. Susceptibility tests by disk diffusion and by E-test and molecular typing by macrorestriction analysis were performed to determine the relatedness of Pseudomonas aeruginosa isolates from three distinct hospitals. The resistance profile of 124 isolates to 8 antimicrobial agents was determined in three different hospitals, in Porto Alegre, Brazil. Frequencies of susceptibility ranged from 43.9% for carbenicillin to 87.7% for ceftazidime. Cross-resistance data of imipenem-resistant isolates indicated that most (70%) were also resistant to carbenicillin, although 30% remained susceptible to ceftazidime and cefepime. In general, susceptibility profiles were not able to determine relatedness among isolates of P. aeruginosa. On the other hand, molecular typing by... Tipo: Info:eu-repo/semantics/article Palavras-chave: Pseudomonas aeruginosa; Antibiotic resistance; Imipenem. Ano: 2002 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000100001 Utility of the ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta-lactamases among enterobacteriaceae BJID Cantarelli,Vlademir Vicente; Inamine,Everton; Brodt,Teresa Cristina Z.; Secchi,Carina; Cavalcante,Bianca C.; Pereira,Fabiana de Souza. Detection of AmpC beta-lactamase production by enterobacteria has been problematic. Contrary to ESBLs, no specific guidelines are available for detection and confirmation of AmpC production by clinical relevant microorganisms. Moreover, some bacterial species may produce inducible AmpC beta-lactamases that can be easily overlooked by routine susceptibility tests. We reported here a new test based on the strong inducible effect of imipenem on AmpC genes and the consequent antagonism with ceftazidime. This test is very simple and proved to be helpful in detecting AmpC-inducible enzymes among several species of clinical isolates. Tipo: Info:eu-repo/semantics/article Palavras-chave: AmpC; Inductible beta-lactamases; Screening tests; Imipenem; Cefoxitin screening. Ano: 2007 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000200014 Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013-2015 BJID Karlowsky,James A.; Hoban,Daryl J.; Hackel,Meredith A.; Lob,Sibylle H.; Sahm,Daniel F.. ABSTRACT Gram-negative ESKAPE pathogens (Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are important etiologic agents of nosocomial infection that are frequently resistant to broad-spectrum antimicrobial agents. Gram-negative ESKAPE pathogens were collected from hospitalized patients in 11 Latin American countries from 2013 to 2015 as part of the Study for Monitoring Antimicrobial Resistance Trends (SMART) global surveillance program. In total, 2113 isolates from intra-abdominal infections (IAI) and 970 isolates from urinary tract infections (UTI) were tested against antimicrobial agents using standardized CLSI broth microdilution methodology. Of the agents tested, amikacin demonstrated the highest rates... Tipo: Info:eu-repo/semantics/other Palavras-chave: Surveillance; SMART; Imipenem; Ertapenem. Ano: 2017 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000300343 Analysis of the use of imipenem at a University Hospital following the restructuring of an antimicrobial audit system BJID Souza,N.P.; Noblat,A.C.B.; Noblat,L.. This study analyzed the use pattern of imipenem following the restructuring of the antimicrobial audit system at a University Hospital. It was an observational study before and after the restructuring of the antimicrobial audit system in a University Hospital from May to August and then from September to December 2006. The criteria of the rational use of imipenem were obtained from a non-systematic revision of the literature. The collection of data on the general characteristics and clinical state of the patient, the infection and the established therapy was carried out in a previously tested instrument. Data was recorded, revised and analyzed in a database built with the software SPSS® for Windows® PC, version 10.0. The statistical analysis had a... Tipo: Info:eu-repo/semantics/article Palavras-chave: Imipenem; Drug use review; Drug use evaluation; Audit system; Antimicrobial policy. Ano: 2008 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000600010 Mortality rate in patients with nosocomial Acinetobacter meningitis from a Brazilian hospital BJID Tuon,Felipe Francisco; Penteado-Filho,Sergio R; Amarante,Diogo; Andrade,Marcio A; Borba,Luis A. BACKGROUND: The mortality rate due to Acinetobacter baumannii nosocomial meningitis (ANM) is high. OBJECTIVE: The aim of this study was to evaluate the factors that have influence over the outcomes in ANM patients. METHODS: A retrospective analysis of 22 cases of ANM was conducted in a hospital with high incidence of multidrug resistance. RESULTS: The mean age of patients was 43 years (21 to 91) and 54.5% were male. All ANM cases occurred within 60 days of admission and the mean duration of illness was of 18.2 days. All cases were associated with previous neurosurgical procedures: elective surgery (27.2%), external shunt (54.4%) and emergency surgery due to trauma (18.1%). Imipenem resistance was observed in 40.9% of cases, but ampicillin/sulbactam... Tipo: Info:eu-repo/semantics/article Palavras-chave: Acinetobacter; Meningitis; Acinetobacter baumannii; Neurosurgery; Imipenem; Ampicillin/sulbactam. Ano: 2010 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500003 Registros recuperados: 6 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco